m_and_a
confidence high
sentiment neutral
materiality 0.65
Denali Capital amends merger pact with Semnur; extends deadline to Sept 2025, addresses Nasdaq delisting
Semnur Pharmaceuticals, Inc.
- Amendment allows Denali to extend business combination deadline to Dec 11, 2025, or later if mutually agreed.
- Outside Date for closing merger extended to Sept 30, 2025; if extension effective, Outside Date becomes Extension Date.
- Modifies covenants to address Denali's Nasdaq delisting and subsequent OTC Markets quotation of its securities.
- Denali will use reasonable best efforts to list its units, shares, and warrants on OTC Markets after Nasdaq delisting.
- Other changes include updating blank-check company status and proxy statement requirements for shareholder vote.